Effective April 21:
Naproxen sodium 220 mg per oral dosage unit (when sold in products labeled with a recommended maximum daily dose of 440 mg, and in package sizes exceeding 6,600 mg) is now Schedule III (changed from Schedule II).
Licensees—what are your responsibilities in the new standards?
November 12, 2024
Learning the standards: newly defined roles for licensees.
Read more ➞
